Open-Label Phase 3 Study to Evaluate the Long-Term Safety and Efficacy of Udenafil Tablets in Male Subjects With Erectile Dysfunction.
Phase of Trial: Phase III
Latest Information Update: 28 Apr 2015
At a glance
- Drugs Udenafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Sponsors Warner Chilcott
- 13 Apr 2012 Actual patient number changed from 1037 to 1027 as reported by ClinicalTrials.gov.
- 18 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Feb 2011 Actual end date changed from May 2011 to Feb 2011 as reported by ClinicalTrials.gov.